Gaetano Guglielmino - 01 Dec 2024 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Commercial Officer
Signature
/s/ Lisa Taylor as Attorney-in-fact for Guy Guglielmino
Issuer symbol
TMCI
Transactions as of
01 Dec 2024
Net transactions value
$0
Form type
4
Filing time
05 Dec 2024, 16:30:13 UTC
Next filing
03 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +330,000 $0.000000 330,000 01 Dec 2024 Direct F1, F2
transaction TMCI Common Stock Award $0 +33,000 +10% $0.000000 363,000 01 Dec 2024 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in four equal annual installments on the first, second, third and fourth anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 includes 330,000 RSUs.
F3 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in four equal annual installments on the first, second, third and fourth anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date. These RSUs represented a portion of the executive's signing bonus which was granted in equity rather than in cash.
F4 Includes 363,000 RSUs.